NVCR
NovoCure Limited
Company Overview
| Mkt Cap | $1.49B | Price | $12.81 |
| Volume | 1.84M | Change | -0.08% |
| P/E Ratio | -8.9 | Open | $12.79 |
| Revenue | $605.2M | Prev Close | $12.82 |
| Net Income | $-168.6M | 52W Range | $10.87 - $34.13 |
| Div Yield | N/A | Target | $26.94 |
| Overall | 45 | Value | 55 |
| Quality | 42 | Technical | 40 |
No chart data available
Stock Overview
Updated DailyNovoCure Limited (NVCR) is a leading diversified company in the business industry, currently trading at $12.81 with a market capitalization of $1.49 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows NVCR with a volume of 1.84 million shares. The stock opened down 0.23% from yesterday's close of $12.82. Current analyst estimates project earnings of $-1.59 per share for this year, with next year targeting $-1.69.
NVCR demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including MYMX, MRVI, NBIX, NSTG.
Key investment considerations for NVCR include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 110.3%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 07:45 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVCR | $12.81 | -0.1% | 1.84M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |